

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.86544975 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.86544975 |
| 3 | muscle filament sliding (GO:0030049) | 6.80493874 |
| 4 | actin-myosin filament sliding (GO:0033275) | 6.80493874 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.77795570 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.46049846 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.46049846 |
| 8 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.45597222 |
| 9 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.33966744 |
| 10 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.24856723 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 6.19116105 |
| 12 | cardiac myofibril assembly (GO:0055003) | 6.09306769 |
| 13 | sarcomere organization (GO:0045214) | 6.05719009 |
| 14 | myofibril assembly (GO:0030239) | 5.96909025 |
| 15 | cardiac muscle contraction (GO:0060048) | 5.81338351 |
| 16 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.79587424 |
| 17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.73510005 |
| 18 | actin-mediated cell contraction (GO:0070252) | 5.69562620 |
| 19 | regulation of actin filament-based movement (GO:1903115) | 5.60320804 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 5.56513906 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 5.56513906 |
| 22 | tryptophan catabolic process (GO:0006569) | 5.56513906 |
| 23 | regulation of relaxation of muscle (GO:1901077) | 5.51709693 |
| 24 | tryptophan metabolic process (GO:0006568) | 5.43576839 |
| 25 | bile acid biosynthetic process (GO:0006699) | 5.41762500 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 5.36970647 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 5.30642961 |
| 28 | kynurenine metabolic process (GO:0070189) | 5.28320331 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 5.27487796 |
| 30 | glyoxylate metabolic process (GO:0046487) | 5.17419590 |
| 31 | protein carboxylation (GO:0018214) | 5.17276633 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.17276633 |
| 33 | urea cycle (GO:0000050) | 5.14515149 |
| 34 | urea metabolic process (GO:0019627) | 5.14515149 |
| 35 | regulation of fibrinolysis (GO:0051917) | 5.07312323 |
| 36 | regulation of cell communication by electrical coupling (GO:0010649) | 5.04831924 |
| 37 | regulation of protein activation cascade (GO:2000257) | 5.00943607 |
| 38 | cardiac muscle hypertrophy (GO:0003300) | 4.99587060 |
| 39 | complement activation, alternative pathway (GO:0006957) | 4.98959496 |
| 40 | sulfur amino acid catabolic process (GO:0000098) | 4.94163899 |
| 41 | cellular response to epinephrine stimulus (GO:0071872) | 4.93202026 |
| 42 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.90287651 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.89128873 |
| 44 | striated muscle contraction (GO:0006941) | 4.88780523 |
| 45 | striated muscle hypertrophy (GO:0014897) | 4.81904436 |
| 46 | response to epinephrine (GO:0071871) | 4.76374286 |
| 47 | nitrogen cycle metabolic process (GO:0071941) | 4.70575151 |
| 48 | regulation of complement activation (GO:0030449) | 4.69149644 |
| 49 | carnitine shuttle (GO:0006853) | 4.68290062 |
| 50 | bile acid metabolic process (GO:0008206) | 4.63287071 |
| 51 | cysteine metabolic process (GO:0006534) | 4.62770458 |
| 52 | tyrosine metabolic process (GO:0006570) | 4.60532316 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 4.59435721 |
| 54 | NADH metabolic process (GO:0006734) | 4.57460760 |
| 55 | protein-lipid complex remodeling (GO:0034368) | 4.57259899 |
| 56 | macromolecular complex remodeling (GO:0034367) | 4.57259899 |
| 57 | plasma lipoprotein particle remodeling (GO:0034369) | 4.57259899 |
| 58 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.55770258 |
| 59 | homocysteine metabolic process (GO:0050667) | 4.54798984 |
| 60 | aromatic amino acid family metabolic process (GO:0009072) | 4.50196792 |
| 61 | acylglycerol homeostasis (GO:0055090) | 4.47747472 |
| 62 | triglyceride homeostasis (GO:0070328) | 4.47747472 |
| 63 | serine family amino acid catabolic process (GO:0009071) | 4.47448467 |
| 64 | actomyosin structure organization (GO:0031032) | 4.43770950 |
| 65 | phospholipid efflux (GO:0033700) | 4.42174726 |
| 66 | muscle hypertrophy (GO:0014896) | 4.39465545 |
| 67 | phospholipid homeostasis (GO:0055091) | 4.38794389 |
| 68 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.37648297 |
| 69 | regulation of cholesterol esterification (GO:0010872) | 4.37411451 |
| 70 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.35501281 |
| 71 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.33391133 |
| 72 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.32904214 |
| 73 | fatty acid transmembrane transport (GO:1902001) | 4.31373420 |
| 74 | heart process (GO:0003015) | 4.29858986 |
| 75 | heart contraction (GO:0060047) | 4.29858986 |
| 76 | actin filament-based movement (GO:0030048) | 4.28649228 |
| 77 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.20616223 |
| 78 | regulation of triglyceride catabolic process (GO:0010896) | 4.17340035 |
| 79 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.16093623 |
| 80 | indolalkylamine metabolic process (GO:0006586) | 4.15540618 |
| 81 | low-density lipoprotein particle remodeling (GO:0034374) | 4.14745890 |
| 82 | plasma lipoprotein particle clearance (GO:0034381) | 4.14630937 |
| 83 | regulation of sarcomere organization (GO:0060297) | 4.14336464 |
| 84 | bile acid and bile salt transport (GO:0015721) | 4.14197130 |
| 85 | regulation of skeletal muscle contraction (GO:0014819) | 4.13797480 |
| 86 | alpha-amino acid catabolic process (GO:1901606) | 4.11389933 |
| 87 | detection of calcium ion (GO:0005513) | 4.09332788 |
| 88 | regulation of striated muscle contraction (GO:0006942) | 4.06518787 |
| 89 | lysine metabolic process (GO:0006553) | 4.03634681 |
| 90 | lysine catabolic process (GO:0006554) | 4.03634681 |
| 91 | cholesterol efflux (GO:0033344) | 4.00824057 |
| 92 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.00281646 |
| 93 | negative regulation of cholesterol transport (GO:0032375) | 3.96389694 |
| 94 | negative regulation of sterol transport (GO:0032372) | 3.96389694 |
| 95 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.94722685 |
| 96 | imidazole-containing compound metabolic process (GO:0052803) | 3.92014941 |
| 97 | positive regulation of lipid catabolic process (GO:0050996) | 3.91554391 |
| 98 | cellular glucuronidation (GO:0052695) | 3.91457629 |
| 99 | coenzyme catabolic process (GO:0009109) | 3.89413584 |
| 100 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.87384295 |
| 101 | benzene-containing compound metabolic process (GO:0042537) | 3.86456152 |
| 102 | creatine metabolic process (GO:0006600) | 3.86115398 |
| 103 | cellular biogenic amine catabolic process (GO:0042402) | 3.84314016 |
| 104 | amine catabolic process (GO:0009310) | 3.84314016 |
| 105 | plasma lipoprotein particle assembly (GO:0034377) | 3.82110055 |
| 106 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.80559488 |
| 107 | cellular amino acid catabolic process (GO:0009063) | 3.78704346 |
| 108 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.77092553 |
| 109 | cell communication involved in cardiac conduction (GO:0086065) | 3.77003428 |
| 110 | muscle tissue morphogenesis (GO:0060415) | 3.72929543 |
| 111 | carnitine metabolic process (GO:0009437) | 3.71868219 |
| 112 | fibrinolysis (GO:0042730) | 3.71794540 |
| 113 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.71064347 |
| 114 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.71064347 |
| 115 | cellular ketone body metabolic process (GO:0046950) | 3.70394121 |
| 116 | skeletal muscle contraction (GO:0003009) | 3.69966593 |
| 117 | regulation of the force of heart contraction (GO:0002026) | 3.69733105 |
| 118 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.68663611 |
| 119 | aldehyde catabolic process (GO:0046185) | 3.68502390 |
| 120 | cardiac muscle cell development (GO:0055013) | 3.67485073 |
| 121 | drug catabolic process (GO:0042737) | 3.67351881 |
| 122 | glycine metabolic process (GO:0006544) | 3.66164246 |
| 123 | * protein activation cascade (GO:0072376) | 3.60659229 |
| 124 | muscle contraction (GO:0006936) | 3.58329569 |
| 125 | cellular modified amino acid catabolic process (GO:0042219) | 3.57800454 |
| 126 | plasma lipoprotein particle organization (GO:0071827) | 3.57404048 |
| 127 | regulation of sequestering of triglyceride (GO:0010889) | 3.57166139 |
| 128 | uronic acid metabolic process (GO:0006063) | 3.55568580 |
| 129 | glucuronate metabolic process (GO:0019585) | 3.55568580 |
| 130 | cholesterol homeostasis (GO:0042632) | 3.54996327 |
| 131 | cardiac muscle adaptation (GO:0014887) | 3.52451690 |
| 132 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.52451690 |
| 133 | muscle hypertrophy in response to stress (GO:0003299) | 3.52451690 |
| 134 | carnitine transmembrane transport (GO:1902603) | 3.52399529 |
| 135 | glutamate metabolic process (GO:0006536) | 3.51186309 |
| 136 | lipoprotein metabolic process (GO:0042157) | 3.50796838 |
| 137 | ethanol oxidation (GO:0006069) | 3.50482376 |
| 138 | sterol homeostasis (GO:0055092) | 3.49990350 |
| 139 | * blood coagulation, intrinsic pathway (GO:0007597) | 3.49942859 |
| 140 | negative regulation of lipase activity (GO:0060192) | 3.49834965 |
| 141 | arginine metabolic process (GO:0006525) | 3.49704089 |
| 142 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.49412903 |
| 143 | positive regulation of fatty acid oxidation (GO:0046321) | 3.47712100 |
| 144 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.46555526 |
| 145 | cofactor catabolic process (GO:0051187) | 3.45727610 |
| 146 | serine family amino acid metabolic process (GO:0009069) | 3.45568228 |
| 147 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.43804723 |
| 148 | cell communication by electrical coupling (GO:0010644) | 3.43583491 |
| 149 | fatty acid oxidation (GO:0019395) | 3.43170552 |
| 150 | organic acid catabolic process (GO:0016054) | 3.42167595 |
| 151 | carboxylic acid catabolic process (GO:0046395) | 3.42167595 |
| 152 | regulation of membrane repolarization (GO:0060306) | 3.41532687 |
| 153 | fatty acid beta-oxidation (GO:0006635) | 3.40888554 |
| 154 | cardiac cell development (GO:0055006) | 3.40433339 |
| 155 | complement activation (GO:0006956) | 3.40151603 |
| 156 | response to nitrosative stress (GO:0051409) | 3.39726358 |
| 157 | lipid oxidation (GO:0034440) | 3.38073283 |
| 158 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.37934322 |
| 159 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.37885762 |
| 160 | complement activation, classical pathway (GO:0006958) | 3.36960414 |
| 161 | protein-lipid complex assembly (GO:0065005) | 3.35984098 |
| 162 | regulation of cardiac muscle contraction (GO:0055117) | 3.35293768 |
| 163 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.34736844 |
| 164 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.34736844 |
| 165 | muscle system process (GO:0003012) | 3.32603569 |
| 166 | striated muscle adaptation (GO:0014888) | 3.26014318 |
| 167 | response to inactivity (GO:0014854) | 3.24892448 |
| 168 | skeletal muscle adaptation (GO:0043501) | 3.20811906 |
| 169 | amino-acid betaine transport (GO:0015838) | 3.19427970 |
| 170 | carnitine transport (GO:0015879) | 3.19427970 |
| 171 | 2-oxoglutarate metabolic process (GO:0006103) | 3.19279902 |
| 172 | regulation of heart rate (GO:0002027) | 3.16960992 |
| 173 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.16646000 |
| 174 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.16646000 |
| 175 | relaxation of cardiac muscle (GO:0055119) | 3.14663110 |
| 176 | cardiac muscle cell action potential (GO:0086001) | 3.09745328 |
| 177 | adult heart development (GO:0007512) | 3.03418272 |
| 178 | negative regulation of protein localization to cell surface (GO:2000009) | 2.99897361 |
| 179 | regulation of heart contraction (GO:0008016) | 2.98520658 |
| 180 | relaxation of muscle (GO:0090075) | 2.97809689 |
| 181 | intracellular lipid transport (GO:0032365) | 2.94873509 |
| 182 | cGMP-mediated signaling (GO:0019934) | 2.94134775 |
| 183 | positive regulation of cation channel activity (GO:2001259) | 2.93897013 |
| 184 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.93763667 |
| 185 | adrenergic receptor signaling pathway (GO:0071875) | 2.93084534 |
| 186 | positive regulation of heart rate (GO:0010460) | 2.92034073 |
| 187 | regulation of muscle system process (GO:0090257) | 2.87286084 |
| 188 | regulation of muscle contraction (GO:0006937) | 2.85702657 |
| 189 | tricarboxylic acid cycle (GO:0006099) | 2.79296511 |
| 190 | glycogen catabolic process (GO:0005980) | 2.78796564 |
| 191 | activation of protein kinase A activity (GO:0034199) | 2.78774808 |
| 192 | regulation of ATPase activity (GO:0043462) | 2.77903338 |
| 193 | regulation of ATP catabolic process (GO:1903289) | 2.77903338 |
| 194 | response to caffeine (GO:0031000) | 2.77746537 |
| 195 | regulation of lipoprotein metabolic process (GO:0050746) | 2.71958786 |
| 196 | oxaloacetate metabolic process (GO:0006107) | 2.71772576 |
| 197 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.71673205 |
| 198 | regulation of cation channel activity (GO:2001257) | 2.71518695 |
| 199 | muscle adaptation (GO:0043500) | 2.71066984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.36244507 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.25045373 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.18978950 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.08755291 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.13357763 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.29726356 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.25251390 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.99929233 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.80612976 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.46253764 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.24644817 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.71065150 |
| 13 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.53334541 |
| 14 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.53334541 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.36664232 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11945525 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.3721328 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.93438593 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92788918 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.70461775 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.69211395 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68394104 |
| 23 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65928903 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65209759 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.62668362 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.59534105 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.56555516 |
| 28 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.52197690 |
| 29 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.47419198 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41396582 |
| 31 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.41126020 |
| 32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36768250 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36113744 |
| 34 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35306722 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33999019 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28537253 |
| 37 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24511473 |
| 38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23025872 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22694391 |
| 40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22519745 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20785841 |
| 42 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.20611335 |
| 43 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20243167 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.19983976 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18300309 |
| 46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.09345328 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.08456530 |
| 48 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08384336 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07436695 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07333491 |
| 51 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06703057 |
| 52 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06703057 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04914003 |
| 54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04884289 |
| 55 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04866934 |
| 56 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04635556 |
| 57 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04590815 |
| 58 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.04506266 |
| 59 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.02792688 |
| 60 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.02218914 |
| 61 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02130760 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00232495 |
| 63 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99860825 |
| 64 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99337124 |
| 65 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98931742 |
| 66 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.98827514 |
| 67 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.98775148 |
| 68 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.98386397 |
| 69 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98130892 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98087707 |
| 71 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97635619 |
| 72 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97540448 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97512732 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97236739 |
| 75 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97080224 |
| 76 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.96835801 |
| 77 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.95756492 |
| 78 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.95186769 |
| 79 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94933057 |
| 80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94635976 |
| 81 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.94298849 |
| 82 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94112404 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93662203 |
| 84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93654533 |
| 85 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93440739 |
| 86 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93059921 |
| 87 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92498406 |
| 88 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91881756 |
| 89 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.91370194 |
| 90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90997914 |
| 91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89959827 |
| 92 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89478150 |
| 93 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88953488 |
| 94 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88612179 |
| 95 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87837793 |
| 96 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.86936230 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86802365 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82098641 |
| 99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82017416 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80805248 |
| 101 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77805274 |
| 102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76246463 |
| 103 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.76199003 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.75741222 |
| 105 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.74005170 |
| 106 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.73941163 |
| 107 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.73685457 |
| 108 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.73277963 |
| 109 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.69816413 |
| 110 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69779735 |
| 111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69534257 |
| 112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.68763125 |
| 113 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.68089321 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67825733 |
| 115 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.65432797 |
| 116 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65165657 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63977757 |
| 118 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.62271235 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59900030 |
| 120 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.59519945 |
| 121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58375981 |
| 122 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58068203 |
| 123 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.56415793 |
| 124 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56081538 |
| 125 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.54269448 |
| 126 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.53364128 |
| 127 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.52604409 |
| 128 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.52314718 |
| 129 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.51457605 |
| 130 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.50955293 |
| 131 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.50390016 |
| 132 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50318139 |
| 133 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.48497056 |
| 134 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.48071625 |
| 135 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.47578967 |
| 136 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.47522522 |
| 137 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.47371047 |
| 138 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.47148344 |
| 139 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.46848154 |
| 140 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.46222791 |
| 141 | RXR_22108803_ChIP-Seq_LS180_Human | 0.45615881 |
| 142 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.45061599 |
| 143 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.44815654 |
| 144 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.44677921 |
| 145 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.44647409 |
| 146 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.44578785 |
| 147 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.44500235 |
| 148 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43891844 |
| 149 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.43731267 |
| 150 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43270996 |
| 151 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.42756611 |
| 152 | CBP_21632823_ChIP-Seq_H3396_Human | 0.41722796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.81733235 |
| 2 | MP0005360_urolithiasis | 6.57417701 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.96902839 |
| 4 | MP0005365_abnormal_bile_salt | 5.79421353 |
| 5 | MP0004084_abnormal_cardiac_muscle | 5.31399896 |
| 6 | MP0000751_myopathy | 5.25801271 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.30491025 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 4.27908528 |
| 9 | MP0004215_abnormal_myocardial_fiber | 4.17447039 |
| 10 | MP0003252_abnormal_bile_duct | 3.75603583 |
| 11 | MP0003646_muscle_fatigue | 3.59357205 |
| 12 | MP0010368_abnormal_lymphatic_system | 3.44688446 |
| 13 | MP0000749_muscle_degeneration | 3.44316795 |
| 14 | MP0010329_abnormal_lipoprotein_level | 3.44140075 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 3.36165497 |
| 16 | MP0004510_myositis | 3.27295463 |
| 17 | MP0005330_cardiomyopathy | 3.12370349 |
| 18 | MP0003195_calcinosis | 2.83524280 |
| 19 | MP0004087_abnormal_muscle_fiber | 2.80194517 |
| 20 | MP0006138_congestive_heart_failure | 2.78544570 |
| 21 | MP0002972_abnormal_cardiac_muscle | 2.72725802 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 2.69565436 |
| 23 | MP0003724_increased_susceptibility_to | 2.59005684 |
| 24 | MP0005083_abnormal_biliary_tract | 2.57839288 |
| 25 | MP0004484_altered_response_of | 2.57436804 |
| 26 | MP0009840_abnormal_foam_cell | 2.55872315 |
| 27 | MP0005620_abnormal_muscle_contractility | 2.45482193 |
| 28 | MP0005332_abnormal_amino_acid | 2.43943135 |
| 29 | MP0000013_abnormal_adipose_tissue | 2.35299443 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 2.33871925 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 2.29619922 |
| 32 | MP0002106_abnormal_muscle_physiology | 2.28135500 |
| 33 | MP0001544_abnormal_cardiovascular_syste | 2.27393151 |
| 34 | MP0005385_cardiovascular_system_phenoty | 2.27393151 |
| 35 | MP0001666_abnormal_nutrient_absorption | 2.16819823 |
| 36 | MP0000609_abnormal_liver_physiology | 2.16025319 |
| 37 | MP0002269_muscular_atrophy | 2.14633392 |
| 38 | MP0000747_muscle_weakness | 2.12409702 |
| 39 | MP0003137_abnormal_impulse_conducting | 2.10618007 |
| 40 | MP0003828_pulmonary_edema | 2.09534073 |
| 41 | MP0004019_abnormal_vitamin_homeostasis | 2.08245765 |
| 42 | MP0008775_abnormal_heart_ventricle | 2.07429786 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 2.01193535 |
| 44 | MP0010630_abnormal_cardiac_muscle | 2.00924113 |
| 45 | MP0002332_abnormal_exercise_endurance | 1.99582071 |
| 46 | MP0000759_abnormal_skeletal_muscle | 1.92950608 |
| 47 | MP0005369_muscle_phenotype | 1.91983067 |
| 48 | MP0002127_abnormal_cardiovascular_syste | 1.91208250 |
| 49 | MP0000750_abnormal_muscle_regeneration | 1.83450687 |
| 50 | MP0004085_abnormal_heartbeat | 1.70902147 |
| 51 | MP0003868_abnormal_feces_composition | 1.69536981 |
| 52 | MP0005319_abnormal_enzyme/_coenzyme | 1.66521622 |
| 53 | MP0001879_abnormal_lymphatic_vessel | 1.63800347 |
| 54 | MP0005165_increased_susceptibility_to | 1.61081899 |
| 55 | MP0009697_abnormal_copulation | 1.51148216 |
| 56 | MP0000343_altered_response_to | 1.51004330 |
| 57 | MP0001764_abnormal_homeostasis | 1.49598947 |
| 58 | MP0002254_reproductive_system_inflammat | 1.38522637 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.38388577 |
| 60 | MP0003221_abnormal_cardiomyocyte_apopto | 1.33589734 |
| 61 | MP0009643_abnormal_urine_homeostasis | 1.33407259 |
| 62 | MP0004233_abnormal_muscle_weight | 1.32547666 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.31595729 |
| 64 | MP0003186_abnormal_redox_activity | 1.28583778 |
| 65 | MP0002108_abnormal_muscle_morphology | 1.26639670 |
| 66 | MP0006054_spinal_hemorrhage | 1.22040098 |
| 67 | MP0003045_fibrosis | 1.19921451 |
| 68 | MP0009763_increased_sensitivity_to | 1.15641973 |
| 69 | MP0000598_abnormal_liver_morphology | 1.15372812 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 1.13443664 |
| 71 | MP0009764_decreased_sensitivity_to | 1.12538051 |
| 72 | MP0003950_abnormal_plasma_membrane | 1.12326244 |
| 73 | MP0001661_extended_life_span | 1.03425904 |
| 74 | MP0003011_delayed_dark_adaptation | 1.02273477 |
| 75 | MP0004130_abnormal_muscle_cell | 1.02156238 |
| 76 | MP0005670_abnormal_white_adipose | 1.01582592 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 0.99287557 |
| 78 | MP0009780_abnormal_chondrocyte_physiolo | 0.99118165 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 0.98448398 |
| 80 | MP0005647_abnormal_sex_gland | 0.97954855 |
| 81 | MP0008469_abnormal_protein_level | 0.97826656 |
| 82 | MP0005408_hypopigmentation | 0.97064727 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 0.96392336 |
| 84 | MP0001958_emphysema | 0.91334259 |
| 85 | MP0003690_abnormal_glial_cell | 0.89633478 |
| 86 | MP0005275_abnormal_skin_tensile | 0.89325687 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 0.88400910 |
| 88 | MP0000003_abnormal_adipose_tissue | 0.87257424 |
| 89 | MP0009642_abnormal_blood_homeostasis | 0.84995092 |
| 90 | MP0000604_amyloidosis | 0.84820394 |
| 91 | MP0005220_abnormal_exocrine_pancreas | 0.83664338 |
| 92 | MP0008004_abnormal_stomach_pH | 0.83308780 |
| 93 | MP0000266_abnormal_heart_morphology | 0.80617809 |
| 94 | MP0008438_abnormal_cutaneous_collagen | 0.80539005 |
| 95 | MP0000733_abnormal_muscle_development | 0.79628423 |
| 96 | MP0009115_abnormal_fat_cell | 0.79196330 |
| 97 | MP0005451_abnormal_body_composition | 0.77321795 |
| 98 | MP0001756_abnormal_urination | 0.75835139 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.75576830 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.75212239 |
| 101 | MP0002128_abnormal_blood_circulation | 0.74742886 |
| 102 | MP0005535_abnormal_body_temperature | 0.71962628 |
| 103 | MP0002876_abnormal_thyroid_physiology | 0.70125894 |
| 104 | MP0002928_abnormal_bile_duct | 0.69641364 |
| 105 | MP0005334_abnormal_fat_pad | 0.69419534 |
| 106 | MP0005084_abnormal_gallbladder_morpholo | 0.67691120 |
| 107 | MP0005376_homeostasis/metabolism_phenot | 0.67456717 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.66368405 |
| 109 | MP0005666_abnormal_adipose_tissue | 0.64740182 |
| 110 | MP0005167_abnormal_blood-brain_barrier | 0.62756691 |
| 111 | MP0002971_abnormal_brown_adipose | 0.59722622 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.56907188 |
| 113 | MP0002295_abnormal_pulmonary_circulatio | 0.55331912 |
| 114 | MP0003075_altered_response_to | 0.54903991 |
| 115 | MP0003279_aneurysm | 0.53194320 |
| 116 | MP0000639_abnormal_adrenal_gland | 0.53078116 |
| 117 | MP0004270_analgesia | 0.51164492 |
| 118 | MP0004272_abnormal_basement_membrane | 0.50815983 |
| 119 | MP0004147_increased_porphyrin_level | 0.50382769 |
| 120 | MP0001984_abnormal_olfaction | 0.50139021 |
| 121 | MP0006036_abnormal_mitochondrial_physio | 0.49610256 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.49522763 |
| 123 | MP0001851_eye_inflammation | 0.49513134 |
| 124 | MP0001944_abnormal_pancreas_morphology | 0.49081009 |
| 125 | MP0005375_adipose_tissue_phenotype | 0.48563292 |
| 126 | MP0003879_abnormal_hair_cell | 0.48506805 |
| 127 | MP0000920_abnormal_myelination | 0.48258685 |
| 128 | MP0001243_abnormal_dermal_layer | 0.48178796 |
| 129 | MP0004043_abnormal_pH_regulation | 0.48138716 |
| 130 | MP0000230_abnormal_systemic_arterial | 0.47637035 |
| 131 | MP0005058_abnormal_lysosome_morphology | 0.46731756 |
| 132 | MP0005464_abnormal_platelet_physiology | 0.46204744 |
| 133 | MP0005448_abnormal_energy_balance | 0.45454903 |
| 134 | MP0002168_other_aberrant_phenotype | 0.45314394 |
| 135 | MP0002998_abnormal_bone_remodeling | 0.45243421 |
| 136 | MP0000767_abnormal_smooth_muscle | 0.45211763 |
| 137 | MP0003953_abnormal_hormone_level | 0.45142581 |
| 138 | MP0004264_abnormal_extraembryonic_tissu | 0.44827964 |
| 139 | MP0002133_abnormal_respiratory_system | 0.44694166 |
| 140 | MP0005388_respiratory_system_phenotype | 0.44694166 |
| 141 | MP0005164_abnormal_response_to | 0.44556692 |
| 142 | MP0005166_decreased_susceptibility_to | 0.44053121 |
| 143 | MP0000249_abnormal_blood_vessel | 0.43693798 |
| 144 | MP0001915_intracranial_hemorrhage | 0.43162406 |
| 145 | MP0005503_abnormal_tendon_morphology | 0.42862279 |
| 146 | MP0003091_abnormal_cell_migration | 0.40247870 |
| 147 | MP0001845_abnormal_inflammatory_respons | 0.38870688 |
| 148 | MP0002837_dystrophic_cardiac_calcinosis | 0.38833549 |
| 149 | MP0005595_abnormal_vascular_smooth | 0.36375033 |
| 150 | MP0008874_decreased_physiological_sensi | 0.35612447 |
| 151 | MP0002693_abnormal_pancreas_physiology | 0.35567135 |
| 152 | MP0006082_CNS_inflammation | 0.35400412 |
| 153 | MP0004381_abnormal_hair_follicle | 0.34793205 |
| 154 | MP0005266_abnormal_metabolism | 0.34641824 |
| 155 | MP0004883_abnormal_blood_vessel | 0.34628001 |
| 156 | MP0002060_abnormal_skin_morphology | 0.34197161 |
| 157 | MP0005395_other_phenotype | 0.33802473 |
| 158 | MP0002419_abnormal_innate_immunity | 0.33490879 |
| 159 | MP0001533_abnormal_skeleton_physiology | 0.33484138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.44730716 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.13421914 |
| 3 | Sudden death (HP:0001699) | 6.89952703 |
| 4 | Bundle branch block (HP:0011710) | 6.62570798 |
| 5 | * Prolonged partial thromboplastin time (HP:0003645) | 6.58429120 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.44811324 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.27243542 |
| 8 | Xanthomatosis (HP:0000991) | 5.95967879 |
| 9 | Muscle fiber splitting (HP:0003555) | 5.83704213 |
| 10 | Muscle fiber inclusion bodies (HP:0100299) | 5.82522524 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 5.79273282 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.73481682 |
| 13 | Nemaline bodies (HP:0003798) | 5.69589965 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 5.56791017 |
| 15 | Exercise-induced myalgia (HP:0003738) | 5.34453522 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 5.15066689 |
| 17 | Type 1 muscle fiber predominance (HP:0003803) | 5.09574321 |
| 18 | Ventricular tachycardia (HP:0004756) | 5.06403927 |
| 19 | Complement deficiency (HP:0004431) | 4.94614529 |
| 20 | Abnormality of the calf musculature (HP:0001430) | 4.93376689 |
| 21 | * Joint hemorrhage (HP:0005261) | 4.82257986 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 4.73021206 |
| 23 | Exercise-induced muscle cramps (HP:0003710) | 4.58810410 |
| 24 | Asymmetric septal hypertrophy (HP:0001670) | 4.56783093 |
| 25 | Atrial fibrillation (HP:0005110) | 4.56088716 |
| 26 | Syncope (HP:0001279) | 4.53929471 |
| 27 | Calf muscle hypertrophy (HP:0008981) | 4.51569434 |
| 28 | Hypolipoproteinemia (HP:0010981) | 4.49292614 |
| 29 | Epidermoid cyst (HP:0200040) | 4.49115189 |
| 30 | Lipoatrophy (HP:0100578) | 4.48094866 |
| 31 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.47890358 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 4.42700104 |
| 33 | Hyperammonemia (HP:0001987) | 4.39039233 |
| 34 | Heart block (HP:0012722) | 4.31872642 |
| 35 | Hypoglycemic coma (HP:0001325) | 4.31305882 |
| 36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.24372997 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 4.20766137 |
| 38 | Right ventricular cardiomyopathy (HP:0011663) | 4.17851637 |
| 39 | Abnormal atrioventricular conduction (HP:0005150) | 4.17829006 |
| 40 | Primary atrial arrhythmia (HP:0001692) | 4.12441148 |
| 41 | Hyperglycinemia (HP:0002154) | 4.08313692 |
| 42 | Myoglobinuria (HP:0002913) | 4.04288063 |
| 43 | Ketosis (HP:0001946) | 4.03710793 |
| 44 | Fat malabsorption (HP:0002630) | 3.96337982 |
| 45 | Supraventricular tachycardia (HP:0004755) | 3.95676028 |
| 46 | Neck muscle weakness (HP:0000467) | 3.94060702 |
| 47 | Distal lower limb muscle weakness (HP:0009053) | 3.89633889 |
| 48 | * Abnormality of the intrinsic pathway (HP:0010989) | 3.88500639 |
| 49 | Supraventricular arrhythmia (HP:0005115) | 3.85406265 |
| 50 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.84350653 |
| 51 | Dilated cardiomyopathy (HP:0001644) | 3.83887992 |
| 52 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.82361177 |
| 53 | Abnormality of methionine metabolism (HP:0010901) | 3.79432639 |
| 54 | Ventricular arrhythmia (HP:0004308) | 3.78454204 |
| 55 | Atrioventricular block (HP:0001678) | 3.73190347 |
| 56 | Increased connective tissue (HP:0009025) | 3.72739899 |
| 57 | Rimmed vacuoles (HP:0003805) | 3.70453015 |
| 58 | Rhabdomyolysis (HP:0003201) | 3.69925728 |
| 59 | Hyperglycinuria (HP:0003108) | 3.68939626 |
| 60 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.67285790 |
| 61 | Subaortic stenosis (HP:0001682) | 3.65805974 |
| 62 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.65805974 |
| 63 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.61338383 |
| 64 | Conjugated hyperbilirubinemia (HP:0002908) | 3.61109146 |
| 65 | Abnormality of glycine metabolism (HP:0010895) | 3.60945932 |
| 66 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.60945932 |
| 67 | Difficulty running (HP:0009046) | 3.60754306 |
| 68 | Increased variability in muscle fiber diameter (HP:0003557) | 3.60426610 |
| 69 | Abnormality of complement system (HP:0005339) | 3.57617149 |
| 70 | Ventricular fibrillation (HP:0001663) | 3.51130550 |
| 71 | Hypercholesterolemia (HP:0003124) | 3.46815219 |
| 72 | Hypoglycemic seizures (HP:0002173) | 3.34217062 |
| 73 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.32028058 |
| 74 | Nonimmune hydrops fetalis (HP:0001790) | 3.31797586 |
| 75 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.29125429 |
| 76 | Ketoacidosis (HP:0001993) | 3.22186930 |
| 77 | Myocardial infarction (HP:0001658) | 3.16387955 |
| 78 | Hyperbilirubinemia (HP:0002904) | 3.14426675 |
| 79 | Abnormality of nucleobase metabolism (HP:0010932) | 3.10762942 |
| 80 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.09892991 |
| 81 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.08330429 |
| 82 | Abnormality of purine metabolism (HP:0004352) | 3.01581698 |
| 83 | Delayed CNS myelination (HP:0002188) | 3.00630511 |
| 84 | Hepatocellular carcinoma (HP:0001402) | 2.99875982 |
| 85 | Areflexia of lower limbs (HP:0002522) | 2.96176678 |
| 86 | Frequent falls (HP:0002359) | 2.88255066 |
| 87 | EMG: neuropathic changes (HP:0003445) | 2.87566177 |
| 88 | Steatorrhea (HP:0002570) | 2.80602797 |
| 89 | Vascular calcification (HP:0004934) | 2.80543230 |
| 90 | Abnormality of the foot musculature (HP:0001436) | 2.75876898 |
| 91 | Abnormality of serum amino acid levels (HP:0003112) | 2.75564586 |
| 92 | Hypochromic microcytic anemia (HP:0004840) | 2.75473380 |
| 93 | Skin nodule (HP:0200036) | 2.72942429 |
| 94 | Esophageal varix (HP:0002040) | 2.68266327 |
| 95 | Palpitations (HP:0001962) | 2.64453846 |
| 96 | Systemic lupus erythematosus (HP:0002725) | 2.63605788 |
| 97 | Prolonged QT interval (HP:0001657) | 2.63600496 |
| 98 | Acanthocytosis (HP:0001927) | 2.60172790 |
| 99 | Foot dorsiflexor weakness (HP:0009027) | 2.59245685 |
| 100 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.59151956 |
| 101 | Glomerulonephritis (HP:0000099) | 2.56631615 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 2.55025736 |
| 103 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55025736 |
| 104 | Cardiovascular calcification (HP:0011915) | 2.53039267 |
| 105 | Generalized muscle weakness (HP:0003324) | 2.50841487 |
| 106 | Ragged-red muscle fibers (HP:0003200) | 2.49273960 |
| 107 | Bulbar palsy (HP:0001283) | 2.48171694 |
| 108 | Generalized aminoaciduria (HP:0002909) | 2.44719047 |
| 109 | Metabolic acidosis (HP:0001942) | 2.42693833 |
| 110 | Spontaneous abortion (HP:0005268) | 2.42031767 |
| 111 | Abnormal EKG (HP:0003115) | 2.40428830 |
| 112 | Mitral stenosis (HP:0001718) | 2.36396719 |
| 113 | Lethargy (HP:0001254) | 2.36001145 |
| 114 | Hemorrhage of the eye (HP:0011885) | 2.35876096 |
| 115 | Scapular winging (HP:0003691) | 2.33580789 |
| 116 | Symptomatic seizures (HP:0011145) | 2.32642415 |
| 117 | Myotonia (HP:0002486) | 2.30710486 |
| 118 | Distal arthrogryposis (HP:0005684) | 2.29962383 |
| 119 | Round ear (HP:0100830) | 2.29597375 |
| 120 | Amyloidosis (HP:0011034) | 2.28572665 |
| 121 | Distal lower limb amyotrophy (HP:0008944) | 2.26610941 |
| 122 | Abnormal gallbladder morphology (HP:0012437) | 2.25420927 |
| 123 | Left ventricular hypertrophy (HP:0001712) | 2.25131748 |
| 124 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.22320378 |
| 125 | Thrombophlebitis (HP:0004418) | 2.22252097 |
| 126 | Hyperglycemia (HP:0003074) | 2.21418030 |
| 127 | Oligomenorrhea (HP:0000876) | 2.21243409 |
| 128 | Enlarged kidneys (HP:0000105) | 2.20275311 |
| 129 | Gowers sign (HP:0003391) | 2.20080151 |
| 130 | Gout (HP:0001997) | 2.18439070 |
| 131 | Pancreatitis (HP:0001733) | 2.16656143 |
| 132 | Gingival bleeding (HP:0000225) | 2.16486353 |
| 133 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.14571665 |
| 134 | Sensorimotor neuropathy (HP:0007141) | 2.13254071 |
| 135 | Sudden cardiac death (HP:0001645) | 2.12563763 |
| 136 | Cholecystitis (HP:0001082) | 2.11208637 |
| 137 | Abnormal gallbladder physiology (HP:0012438) | 2.11208637 |
| 138 | Myopathic facies (HP:0002058) | 2.10075913 |
| 139 | Renal cortical cysts (HP:0000803) | 2.08168953 |
| 140 | Irritability (HP:0000737) | 2.05945647 |
| 141 | Cholelithiasis (HP:0001081) | 2.05244549 |
| 142 | Cerebral edema (HP:0002181) | 2.05113631 |
| 143 | Late onset (HP:0003584) | 2.04299696 |
| 144 | Polycythemia (HP:0001901) | 2.04019478 |
| 145 | Difficulty climbing stairs (HP:0003551) | 2.03392238 |
| 146 | Steppage gait (HP:0003376) | 2.02201553 |
| 147 | Cerebral hemorrhage (HP:0001342) | 2.00554279 |
| 148 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.00219206 |
| 149 | Spastic diplegia (HP:0001264) | 1.97467936 |
| 150 | Muscular dystrophy (HP:0003560) | 1.96033404 |
| 151 | Menorrhagia (HP:0000132) | 1.94960300 |
| 152 | Neonatal onset (HP:0003623) | 1.94320864 |
| 153 | Elevated hepatic transaminases (HP:0002910) | 1.92476539 |
| 154 | Limb-girdle muscle atrophy (HP:0003797) | 1.92076822 |
| 155 | Elevated alkaline phosphatase (HP:0003155) | 1.91985925 |
| 156 | Rickets (HP:0002748) | 1.91471689 |
| 157 | Nephritis (HP:0000123) | 1.89890714 |
| 158 | Dysmetric saccades (HP:0000641) | 1.88688589 |
| 159 | Alkalosis (HP:0001948) | 1.87780199 |
| 160 | Poikilocytosis (HP:0004447) | 1.87156233 |
| 161 | Muscle stiffness (HP:0003552) | 1.87089830 |
| 162 | Proximal tubulopathy (HP:0000114) | 1.84455999 |
| 163 | Spinal rigidity (HP:0003306) | 1.83669182 |
| 164 | Abnormality of the gallbladder (HP:0005264) | 1.83091720 |
| 165 | Hydroxyprolinuria (HP:0003080) | 1.82011999 |
| 166 | Abnormality of proline metabolism (HP:0010907) | 1.82011999 |
| 167 | Pulmonary embolism (HP:0002204) | 1.81446775 |
| 168 | Opisthotonus (HP:0002179) | 1.80371158 |
| 169 | Vomiting (HP:0002013) | 1.80359485 |
| 170 | Spontaneous hematomas (HP:0007420) | 1.80152628 |
| 171 | Proximal amyotrophy (HP:0007126) | 1.76155874 |
| 172 | Weak cry (HP:0001612) | 1.70593859 |
| 173 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.68441838 |
| 174 | Ulnar deviation of the wrist (HP:0003049) | 1.67761027 |
| 175 | Toxemia of pregnancy (HP:0100603) | 1.67080179 |
| 176 | Increased serum pyruvate (HP:0003542) | 1.66139928 |
| 177 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.65669025 |
| 178 | Palmoplantar keratoderma (HP:0000982) | 1.64915518 |
| 179 | Aortic aneurysm (HP:0004942) | 1.59715019 |
| 180 | Facial diplegia (HP:0001349) | 1.59671762 |
| 181 | Pheochromocytoma (HP:0002666) | 1.59100636 |
| 182 | Malignant hyperthermia (HP:0002047) | 1.56354847 |
| 183 | Lower limb amyotrophy (HP:0007210) | 1.55771728 |
| 184 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.55481677 |
| 185 | Congestive heart failure (HP:0001635) | 1.55395848 |
| 186 | Slender build (HP:0001533) | 1.44254345 |
| 187 | Bradycardia (HP:0001662) | 1.43168103 |
| 188 | Neuroendocrine neoplasm (HP:0100634) | 1.42412578 |
| 189 | Osteolytic defects of the hand bones (HP:0009699) | 1.41136485 |
| 190 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.41136485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 7.38118484 |
| 2 | OBSCN | 6.88326690 |
| 3 | TTN | 5.15006401 |
| 4 | TIE1 | 4.77231598 |
| 5 | MYLK | 4.56790909 |
| 6 | BCKDK | 3.45533390 |
| 7 | INSRR | 3.39908965 |
| 8 | ERN1 | 3.22255536 |
| 9 | SIK1 | 3.05163802 |
| 10 | PHKG1 | 3.04888464 |
| 11 | PHKG2 | 3.04888464 |
| 12 | FGFR4 | 2.90427527 |
| 13 | DMPK | 2.63593298 |
| 14 | PTK6 | 2.49746270 |
| 15 | STK16 | 2.36334252 |
| 16 | MAP3K6 | 2.17889106 |
| 17 | TGFBR2 | 2.14523674 |
| 18 | MAP3K14 | 2.09086381 |
| 19 | TAOK3 | 2.05910838 |
| 20 | JAK1 | 1.97751479 |
| 21 | DAPK2 | 1.68950686 |
| 22 | FRK | 1.68454119 |
| 23 | TRPM7 | 1.67142669 |
| 24 | MUSK | 1.65691773 |
| 25 | TAOK1 | 1.60434171 |
| 26 | MARK1 | 1.57703147 |
| 27 | FLT3 | 1.57004249 |
| 28 | ERBB4 | 1.53139270 |
| 29 | TYK2 | 1.47343169 |
| 30 | PIK3CG | 1.46982760 |
| 31 | LATS1 | 1.45884942 |
| 32 | JAK2 | 1.38173114 |
| 33 | JAK3 | 1.37289324 |
| 34 | IRAK3 | 1.31290782 |
| 35 | MAP3K5 | 1.28677086 |
| 36 | TGFBR1 | 1.28076795 |
| 37 | RIPK1 | 1.26000530 |
| 38 | MAPKAPK3 | 1.25765678 |
| 39 | MAPK15 | 1.24783493 |
| 40 | MAP3K3 | 1.20925072 |
| 41 | TRIB3 | 1.18618324 |
| 42 | PKN2 | 1.18334359 |
| 43 | PRKD1 | 1.17759698 |
| 44 | ROCK1 | 1.16453791 |
| 45 | MAPK11 | 1.15930083 |
| 46 | PDK2 | 1.15241881 |
| 47 | EPHB1 | 1.11815135 |
| 48 | PAK3 | 1.11085276 |
| 49 | NEK9 | 1.10646639 |
| 50 | VRK1 | 1.08458320 |
| 51 | CAMK2D | 1.07813626 |
| 52 | GRK1 | 0.96177920 |
| 53 | CAMK1 | 0.94396130 |
| 54 | CDC42BPA | 0.92550960 |
| 55 | EPHB2 | 0.92009006 |
| 56 | EPHA3 | 0.90219813 |
| 57 | MST1R | 0.89811099 |
| 58 | PIK3CA | 0.87163365 |
| 59 | FGFR2 | 0.85441859 |
| 60 | STK38 | 0.85083050 |
| 61 | NEK1 | 0.84179360 |
| 62 | GSK3A | 0.81542792 |
| 63 | AKT3 | 0.81158708 |
| 64 | BLK | 0.78987543 |
| 65 | GRK7 | 0.78929992 |
| 66 | DYRK1B | 0.78737569 |
| 67 | PRKAA2 | 0.77758350 |
| 68 | FGFR3 | 0.77755341 |
| 69 | MAP3K13 | 0.77459692 |
| 70 | ABL2 | 0.77315942 |
| 71 | CAMK1D | 0.76798715 |
| 72 | PTK2B | 0.75285002 |
| 73 | PKN1 | 0.74215774 |
| 74 | PNCK | 0.72815917 |
| 75 | MST4 | 0.71460675 |
| 76 | CAMK2G | 0.71403746 |
| 77 | MAP2K4 | 0.71208457 |
| 78 | SGK2 | 0.70213430 |
| 79 | CAMK2A | 0.69929804 |
| 80 | CDK6 | 0.69285323 |
| 81 | ROCK2 | 0.68408143 |
| 82 | BMPR1B | 0.68157494 |
| 83 | LIMK1 | 0.67310554 |
| 84 | SGK3 | 0.67135724 |
| 85 | CSNK1G1 | 0.66535775 |
| 86 | CAMK2B | 0.65488154 |
| 87 | TBK1 | 0.65359471 |
| 88 | MAP3K7 | 0.64774534 |
| 89 | MET | 0.64719455 |
| 90 | PRKG1 | 0.64715329 |
| 91 | PRPF4B | 0.63803420 |
| 92 | DDR2 | 0.63790524 |
| 93 | MAPK7 | 0.61884467 |
| 94 | MAPK13 | 0.61688061 |
| 95 | LATS2 | 0.60454222 |
| 96 | MAP2K3 | 0.60076348 |
| 97 | NLK | 0.59536045 |
| 98 | CAMK4 | 0.56761987 |
| 99 | SGK223 | 0.55569813 |
| 100 | SGK494 | 0.55569813 |
| 101 | DAPK3 | 0.54724028 |
| 102 | MAPK12 | 0.54627640 |
| 103 | KSR2 | 0.54047455 |
| 104 | IGF1R | 0.52609844 |
| 105 | PDPK1 | 0.50126608 |
| 106 | ERBB2 | 0.48979680 |
| 107 | WNK4 | 0.47955214 |
| 108 | MAPK4 | 0.47855648 |
| 109 | STK38L | 0.47582286 |
| 110 | AKT2 | 0.47237988 |
| 111 | ZAP70 | 0.46742014 |
| 112 | CSK | 0.46406689 |
| 113 | PRKACG | 0.46283543 |
| 114 | STK3 | 0.46229756 |
| 115 | BMX | 0.45415832 |
| 116 | CDK9 | 0.44940497 |
| 117 | CHUK | 0.43826120 |
| 118 | PRKAA1 | 0.43404638 |
| 119 | PRKACB | 0.43165931 |
| 120 | TAOK2 | 0.42182257 |
| 121 | UHMK1 | 0.41490320 |
| 122 | MAP3K4 | 0.41481540 |
| 123 | MAP2K1 | 0.40828627 |
| 124 | PRKCE | 0.40756224 |
| 125 | PRKACA | 0.40529466 |
| 126 | RPS6KA3 | 0.40485752 |
| 127 | MOS | 0.40441447 |
| 128 | GRK5 | 0.40055907 |
| 129 | PRKCZ | 0.39435886 |
| 130 | PDGFRA | 0.38348620 |
| 131 | PRKCH | 0.37997963 |
| 132 | EPHA2 | 0.36850763 |
| 133 | LMTK2 | 0.35337669 |
| 134 | EGFR | 0.34869945 |
| 135 | PDK1 | 0.34341795 |
| 136 | CDK5 | 0.31872231 |
| 137 | ZAK | 0.30967108 |
| 138 | PRKCQ | 0.30260877 |
| 139 | SGK1 | 0.28199391 |
| 140 | PTK2 | 0.28108249 |
| 141 | MAPK10 | 0.27732941 |
| 142 | CCNB1 | 0.27395422 |
| 143 | IKBKE | 0.27043368 |
| 144 | CSNK1A1L | 0.26766604 |
| 145 | NUAK1 | 0.26325252 |
| 146 | MAP3K2 | 0.25549812 |
| 147 | RPS6KC1 | 0.24128184 |
| 148 | MAP2K2 | 0.22055581 |
| 149 | PINK1 | 0.22047598 |
| 150 | ABL1 | 0.21265970 |
| 151 | IRAK4 | 0.21251045 |
| 152 | CAMK1G | 0.21243182 |
| 153 | RET | 0.21177766 |
| 154 | PRKCD | 0.19406529 |
| 155 | PDGFRB | 0.19332008 |
| 156 | INSR | 0.19325538 |
| 157 | MAPK3 | 0.19310705 |
| 158 | LYN | 0.18853964 |
| 159 | FER | 0.18074986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.42056826 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.84139011 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.76875632 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.49957961 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31493291 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.03963954 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83200467 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.80229760 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79182379 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.78993557 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65331855 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.43383767 |
| 13 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.40233077 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.38506490 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.32893491 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.31760771 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.26563663 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25930458 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.07658666 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06256545 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.05881419 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02451584 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 2.01986805 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.01683284 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.99139769 |
| 26 | Circadian rhythm_Homo sapiens_hsa04710 | 1.92820384 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90283132 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.88165719 |
| 29 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.86207865 |
| 30 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.78906245 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.78832250 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.75327819 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74328568 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71324047 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.71256392 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.58466035 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57292422 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.54150299 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.53197760 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51678803 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.44437876 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.42951192 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39806680 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38700879 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.38530122 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35930129 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34730695 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.33526895 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30165679 |
| 50 | Renin secretion_Homo sapiens_hsa04924 | 1.27512721 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.27079748 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26998144 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19862314 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.05511262 |
| 55 | Focal adhesion_Homo sapiens_hsa04510 | 1.03949401 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.02416200 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02057449 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.01404190 |
| 59 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.00891827 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.99630589 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98805432 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98486077 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96179166 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.95118142 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94998534 |
| 66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.91383333 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.91181216 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88191635 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88118082 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.86193188 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85927177 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82555833 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79945029 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74709159 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.74492064 |
| 76 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.73095359 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67586645 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65605682 |
| 79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64520410 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61631026 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61354955 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56724478 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56697453 |
| 84 | Long-term potentiation_Homo sapiens_hsa04720 | 0.56502829 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55154948 |
| 86 | Gap junction_Homo sapiens_hsa04540 | 0.52523323 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.51251117 |
| 88 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49806712 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49687617 |
| 90 | Insulin secretion_Homo sapiens_hsa04911 | 0.49593783 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48403047 |
| 92 | Salivary secretion_Homo sapiens_hsa04970 | 0.45640995 |
| 93 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.44968212 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44532328 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44389095 |
| 96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43931637 |
| 97 | Adherens junction_Homo sapiens_hsa04520 | 0.42828536 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42168760 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40228672 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.39634545 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38654566 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38318019 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35292878 |
| 104 | Malaria_Homo sapiens_hsa05144 | 0.34160157 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33861868 |
| 106 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.32285120 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31879156 |
| 108 | Morphine addiction_Homo sapiens_hsa05032 | 0.31254036 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30642980 |
| 110 | GABAergic synapse_Homo sapiens_hsa04727 | 0.28868371 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.28225544 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.24678153 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23220598 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.20930346 |
| 115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20534207 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19390772 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.12822142 |
| 118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.11087523 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.10660072 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.10128195 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.07453686 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | 0.01501999 |
| 123 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.1324913 |
| 124 | Pertussis_Homo sapiens_hsa05133 | -0.1218091 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | -0.1186161 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1170399 |
| 127 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1161140 |
| 128 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.1124402 |
| 129 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1019987 |
| 130 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.1001690 |
| 131 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0952146 |
| 132 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0888396 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0851364 |
| 134 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0814554 |
| 135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0764642 |
| 136 | Lysosome_Homo sapiens_hsa04142 | -0.0660304 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0370309 |
| 138 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0240664 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0233429 |

